loading page

Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations
  • +2
  • Shreya Patel,
  • Misty Thompson,
  • James Slaven,
  • Don Sanders,
  • Clement Ren
Shreya Patel
Indiana University School of Medicine
Author Profile
Misty Thompson
Indiana University School of Medicine
Author Profile
James Slaven
Indiana University Purdue University at Indianapolis
Author Profile
Don Sanders
Indiana University School of Medicine
Author Profile
Clement Ren
Indiana University System
Author Profile

Abstract

To assess the impact of COVID-19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 vs 2020. Restrictions on social interaction due to the COVID-19 pandemic were associated with a lower rate of PEx at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF.

Peer review status:ACCEPTED

07 Nov 2020Submitted to Pediatric Pulmonology
09 Nov 2020Submission Checks Completed
09 Nov 2020Assigned to Editor
21 Nov 2020Reviewer(s) Assigned
05 Dec 2020Review(s) Completed, Editorial Evaluation Pending
05 Dec 2020Editorial Decision: Revise Minor
20 Dec 20201st Revision Received
21 Dec 2020Submission Checks Completed
21 Dec 2020Assigned to Editor
21 Dec 2020Reviewer(s) Assigned
24 Dec 2020Review(s) Completed, Editorial Evaluation Pending
26 Dec 2020Editorial Decision: Accept